Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 1, 2024,...
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
April 18, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024 08:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
March 13, 2024 16:05 ET
|
Anika Therapeutics Inc.
Revenue growth and adjusted EBITDA1 exceeded expectations in the fourth quarter and full year OA Pain Management achieved record annual revenues of $102 million, up 11% in 2023 Announces cost...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 08, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., March 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on March 1,...
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
February 27, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
February 13, 2024 09:00 ET
|
Anika Therapeutics Inc.
Announcing the limited market release of X-Twist™ Fixation System with biocomposite suture anchor for rotator cuff and other soft tissue repair at AAOS Focusing on its full Regenerative, Sports...
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
November 28, 2023 09:00 ET
|
Anika Therapeutics Inc.
Integrity marks Anika’s entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion of its proprietary hyaluronic acid (HA) regenerative portfolio BEDFORD,...
Anika to Participate in Upcoming Investor Conferences
November 07, 2023 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
November 02, 2023 16:05 ET
|
Anika Therapeutics Inc.
Revenue Growth Exceeded Expectations in the Third Quarter and Year-To-Date, with Joint Preservation and Restoration up 14% and 10% and OA Pain Management up 2% and 11%, Respectively ...